To establish normal reference values for the foetal LVIRT and myocardial contraction duration using respectively echocardiographic Doppler tracings and cTDI at a foetal age around 20, 28 and 30 weeks* gestation. These reference values will be…
ID
Source
Brief title
Condition
- Cardiac arrhythmias
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The LVIRT and the myocardial contraction duration will be measured using
respectively echocardiographic Doppler tracings and cTDI at a foetal age around
20, 28 and 30 weeks* gestation.
Secondary outcome
Other mechanical foetal echocardiographic parameters at 20, 28 en 30 weeks'
gestation.
Background summary
The congenital long-QT syndrome (LQTS) is an inheritable cardiac arrhythmia
disorder and is associated with sudden cardiac death (SCD) due to malignant
ventricular arrhythmias. When LQTS presents in utero or during the first week
of life, the prognosis may be poor. Timely appropriate therapy can manage
foetal arrhythmias and reverse foetal heart failure and thus early diagnosis
may be lifesaving even in the perinatal period. The foetal echocardiogram is
the main diagnostic tool for evaluating foetal arrhythmias providing accurate
information about the atrial and ventricular contractions that indirectly
reflect the P-wave and QRS-complex. Currently echocardiography cannot assess a
derivative of the QT-interval. In order to improve the role of the foetal
echocardiogram in the diagnosis of LQTS, mechanical parameters that
theoretically would be the correlation of the cardiac repolarization have been
studied. Mechanical abnormalities in the contraction and relaxation pattern in
adult and paediatric LQTS-patients were found and could be used for the
diagnosis and risk-stratification in LQTS. These abnormalities can be detected
with echocardiographic Doppler tracings and colour Tissue Doppler Imaging
(cTDI). Follow up studies found that LVIRT and the myocardial contraction
duration were prolonged in LQTS-foetuses and had a high distinctive character
for the diagnosis of LQTS and a strong correlation with the QT-interval.
However, establishment of normal ranges of the LVIRT and myocardial contraction
duration in healthy foetuses is needed. Furthermore, these previous results
should be validated in a larger cohort of LQTS foetuses.
Study objective
To establish normal reference values for the foetal LVIRT and myocardial
contraction duration using respectively echocardiographic Doppler tracings and
cTDI at a foetal age around 20, 28 and 30 weeks* gestation. These reference
values will be compared with foetuses with postnatally confirmed LQTS.
Study design
This is a prospective observational cohort study.
Study burden and risks
In this echocardiogram Doppler tracings and cTDI recordings will be obtained
around week 20, 28 and 30 weeks* gestation. In order to do this, patients will
be asked to come to the Academic Medical Center in Amsterdam for three
additional times. This study does not have an advantage for the participating
patients. However, these additional examinations will be performed by a
paediatric cardiologist who will first confirm that the foetus has a normal
heart. This knowledge could be of emotional benefit to the mother. Should an
abnormality be detected the normal management of that problem will be
initiated. Women who are pregnant with a foetus with a 50% risk of LQTS will be
asked to come to the hospital for two extra visits.
Meibergdreef 9
Amsterdam 1105AZ
NL
Meibergdreef 9
Amsterdam 1105AZ
NL
Listed location countries
Inclusion criteria
* The mother must be living in The Netherlands.
* The mother is between 18 and 40 years of age.
* The mother should be pregnant and have had standard obstetric care without
abnormalities
Exclusion criteria
* Maternal medical history of conditions that are at risk for affecting the
foetus (i.e pregestational diabetes, epilepsy, HIV, hepatitis B)
* Maternal use of medication that affects the QTc-interval
(https://crediblemeds.org/pdftemp/pdf/CombinedList.pdf)
* Foetuses of consanguineous parents
* Foetuses with congenital heart disease, chromosomal syndromes, cephalic
disorders
* Maternal cigarette or alcohol usage during pregnancy
* Maternal obesity before pregnancy (BMI * 30)
* Abnormalities on the previous foetal ultrasound.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL69502.018.19 |